Autopsy report · NCT00296166

Catheter Ablation Versus Thoracoscopic Ablation to Patients With Permanent Atrial Fibrillation

“Patients with permanent AF are seldomly symptomatic enough to justify intervention. We decided to stop inclusion due to low recruitment rate.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 9 months before it started.
• Ran for about 4 years before it stopped.
• 200 participants planned (an estimate, not an actual count).
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Copenhagen University Hospital, Rigshospitalet

Sponsor type

University, hospital or other

Conditions

Atrial Fibrillation

Interventions

Catheter ablation; Thoracoscopic epicardial ablation

Participants

200 (planned, not actual)

Sites

1

Countries

Denmark

Trials that died the same way

• Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery
  “Less patients than expected for inclusion, therefore recruitment is too low” (68% match in meaning)
• RCVS: The Rational Approach to Diagnosis and Treatment
  “Failure to recruit patients meeting inclusion criteria.” (63% match in meaning)
• Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer
  “Too narrow inclusion criteria. Impossible to recruit patients.” (63% match in meaning)
• Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE)
  “The rate of inclusion is too low to hope to reach the target of 800 patients. 59 patients were included, and their data will not meet the research objectives. The sponsor has decided to prematurely stop inclusions on January 13, 2022.” (62% match in meaning)
• Cetrotide Treatment Optimization
  “Due to limited rate of patient inclusion” (62% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.